Veterinary Medicine Information website

Marfloxin 5 mg Tablets for Cats and Dogs

Authorised
  • Marbofloxacin

Product identification

Medicine name:
Marfloxin 5 mg Tablets for Cats and Dogs
Active substance:
  • Marbofloxacin
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Marbofloxacin
    5.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA93
Authorisation status:
  • Valid
Authorised in:
  • Slovenia
Available in:
  • Slovenia
Package description:
  • box containing 100 tablets (10 blister)
  • box containing 10 tablets (1 blister)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • KRKA tovarna zdravil d.d. Novo mesto
  • TAD Pharma GmbH
  • Krka-Farma d.o.o.
Responsible authority:
  • Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
  • DC/V/0416/001
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0317/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 22/12/2023
Download

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 29/10/2025

eu-PUAR-esv0317001-dcp-marfloxin-5-mg-tablets-for-cats-and-dogs-en.pdf

English (PDF)
Published on: 21/12/2023
Download